Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases

Clinical trial NCT07011849 · WITHDRAWN

Trial details

NCT number: NCT07011849
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma Brain Metastasis

Start date: 2025-06-04
Primary completion: 2025-08-07
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.